NuPathe Market Cap:
92.16M for May 20, 2013NuPathe Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 20, 2013 | 92.16M |
| May 17, 2013 | 93.03M |
| May 16, 2013 | 91.57M |
| May 15, 2013 | 93.75M |
| May 14, 2013 | 93.61M |
| May 13, 2013 | 96.23M |
| May 10, 2013 | 96.52M |
| May 9, 2013 | 96.52M |
| May 8, 2013 | 96.81M |
| May 7, 2013 | 95.64M |
| May 6, 2013 | 95.64M |
| May 3, 2013 | 97.10M |
| May 2, 2013 | 95.94M |
| May 1, 2013 | 97.10M |
| April 30, 2013 | 97.68M |
| April 29, 2013 | 97.39M |
| April 26, 2013 | 98.26M |
| April 25, 2013 | 97.97M |
| April 24, 2013 | 99.37M |
| April 23, 2013 | 100.88M |
| April 22, 2013 | 98.55M |
| April 19, 2013 | 100.44M |
| April 18, 2013 | 102.04M |
| April 17, 2013 | 104.37M |
| April 16, 2013 | 105.53M |
| April 15, 2013 | 104.37M |
| April 12, 2013 | 105.24M |
| April 11, 2013 | 104.95M |
| April 10, 2013 | 106.11M |
| April 9, 2013 | 105.82M |
| April 8, 2013 | 106.40M |
| April 5, 2013 | 104.66M |
| April 4, 2013 | 104.66M |
| April 3, 2013 | 101.75M |
| April 2, 2013 | 105.24M |
| April 1, 2013 | 103.20M |
| March 28, 2013 | 100.30M |
| March 27, 2013 | 99.42M |
| March 26, 2013 | 99.42M |
| March 25, 2013 | 106.40M |
| March 22, 2013 | 71.49M |
| March 21, 2013 | 71.29M |
| March 20, 2013 | 72.29M |
| March 19, 2013 | 69.08M |
| March 18, 2013 | 70.28M |
| March 15, 2013 | 69.28M |
| March 14, 2013 | 69.28M |
| March 13, 2013 | 69.08M |
| March 12, 2013 | 68.08M |
| March 11, 2013 | 68.68M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
PATH Market Cap Benchmarks
| Companies | |
|---|---|
| Halozyme Therapeutics | 900.46M |
| Cadence Pharmaceuticals | 589.03M |
| Cytori Therapeutics | 176.67M |
PATH Market Cap Rankings
| Overall |
52nd percentile 3823 of 8002 |
| Sector |
37th percentile 408 of 650 in Healthcare |
| Industry |
40th percentile 142 of 237 in Biotechnology |
PATH Market Cap Range, Past 5 Years
| Minimum | 23.60M | Dec 21 2011 |
| Maximum | 139.79M | Aug 6 2010 |
| Average | 73.46M |
